<DOC>
	<DOCNO>NCT02519556</DOCNO>
	<brief_summary>Atopic dermatitis ( AD ) immune disorder , characterize chronic skin inflammation relapsing , whose prevalence increase worldwide . Its exact etiology remain unknown . The hypothesis appropriate early stimulation intestinal flora contributes establishment immune system balance lead use probiotic prevention treatment AD several clinical experimental study . Therefore , objective study evaluate clinical efficacy mixture probiotic ( Lactobacillus Bifidobacterium ) child AD SCORAD ( score atopic dermatitis ) evaluate effect medication follow laboratory parameter : skin prick test , total serum immunoglobulin E ( IgE ) , inflammation composite ( interferon gamma [ ɣ - IFN ] , interleukins [ IL1-β , IL-4 , IL-6 , IL-8 ] tumor necrosis factor alpha ) immune tolerance composite ( IL-10 , IL-17 transform growth factor beta [ TGF - β ] ) .</brief_summary>
	<brief_title>Trial Effectiveness Combined Probiotics Atopic Dermatitis Children</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinical diagnosis Atopic Dermatitis Children 6 month . Teens low 19 year Diagnostic presence clinical sign suggest acute chronic skin disease , well pertinent study , may affect outcome research . Being use drug affect systemically course disease , systemic corticosteroid immunosuppressant , least 30 day . Allergy severe adverse reaction attributable administration probiotic . Non adherence treatment ( ie present regular use , prescribe ) least one continuous month . Lack attendance 50 % rating ( clinical and/or laboratory ) hold search . Patient 's request ( responsible 's request )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Awareness</keyword>
	<keyword>Immune tolerance</keyword>
</DOC>